Effects of exercise and lifestyle intervention on oxidative stress in chronic kidney disease

Redox Rep. 2017 May;22(3):127-136. doi: 10.1080/13510002.2016.1276314. Epub 2017 Jan 11.

Abstract

Objectives: Determine the effects of a 12-month exercise and lifestyle intervention program on changes in plasma biomarkers of oxidative stress in pre-dialysis chronic kidney disease (CKD) patients.

Methods: A total of 136 stage 3-4 CKD patients were randomized to receive standard nephrological care with (N = 72) or without (N = 64) a lifestyle and exercise intervention for 12 months. Plasma total F2-isoprostanes (IsoP), glutathione peroxidase (GPX) activity, total antioxidant capacity (TAC), anthropometric and biochemical data were collected at baseline and at 12 months.

Results: There were no significant differences between groups at baseline. There were no significant differences in changes for standard care and lifestyle intervention, respectively, in IsoP (p = 0.88), GPX (p = 0.87), or TAC (p = 0.56). Patients identified as having high IsoP at baseline (>250 pg/mL) had a greater decrease in IsoP with lifestyle intervention compared to standard care; however, the difference was not statistically significant (p = 0.06). There was no difference in the change in kidney function (eGFR) between standard care and lifestyle intervention (p = 0.33).

Discussion: Exercise and lifestyle modification in stage 3-4 CKD did not produce changes in systemic biomarkers of oxidative stress over a 12-month period, but patients with high IsoP may benefit most from the addition of intervention to standard care.

Keywords: Chronic kidney disease; exercise and lifestyle modification; oxidative stress.

Publication types

  • Comparative Study

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antioxidants / analysis
  • Biomarkers / analysis*
  • Case-Control Studies
  • Exercise Therapy*
  • Female
  • Humans
  • Life Style*
  • Male
  • Middle Aged
  • Oxidation-Reduction
  • Oxidative Stress*
  • Renal Insufficiency, Chronic / physiopathology
  • Renal Insufficiency, Chronic / therapy*
  • Young Adult

Substances

  • Antioxidants
  • Biomarkers

Grants and funding

The work was supported by the National Health and Medical Research Council Australia, through Australian Fellowship award [# 511081] to Prof. Wendy Hoy, and the Centre for Research Excellence (Chronic Kidney Disease in Queensland, CKD.QLD) and the Centre for Chronic Disease at the University of Queensland.